Discovery of Orally Available Prodrugs of Itaconate and Derivatives

    January 2025 in “ Journal of Medicinal Chemistry
    Chae Bin Lee, Ivan Šnajdr, Lukáš Tenora, Jesse Alt, Sadakatali S. Gori, Marcela Krečmerová, R. Michael Maragakis, James Paule, Sandhya P. Tiwari, Jitesh Iyer, Rashmi Talwar, Luis A. Garza, Pavel Majer, Barbara S. Slusher, Rana Rais
    Studysummary This study identified orally available itaconate derivatives that improve cellular permeability and bioavailability, with specific POC-based prodrugs showing significant inhibition of inflammatory cytokines in human epidermal keratinocytes and favorable oral pharmacokinetics, highlighting their potential for treating systemic and skin disorders.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →

    Research cited in this study

    6 / 6 results